Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for chronic bronchitis. Controversies

P Ball1, G Tillotson, R Wilson

  • 1Infectious Disease Unit, Victoria Hospital, Kirkcaldy, Fife, Scotland, UK.

Presse Medicale (Paris, France : 1983)
|January 21, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.

The Journal of hospital infection·2020
Same author

Performance of Sri Lankan FRAX algorithm without bone mineral density and with Quantitative Ultrasound data input

The Ceylon medical journal·2019
Same author

Research abstracts presented at the Eastern Allergy Conference, Palm Beach, Florida, May 6-9, 2010.

Allergy and asthma proceedings·2017
Same author

Estrogen responsiveness of progestin receptor induction in the pituitary, preoptic-hypothalamic brain and uterus of neonatally estrogenized female rats.

Brain research·2013
Same author

Reliability of hindfoot goniometry when using a flexible electrogoniometer.

Clinical biomechanics (Bristol, Avon)·2013
Same author

U.N.R.R.A. brings health and hope to the victims of total war.

Modern hospital·2010

Antibiotic therapy for chronic bronchitis exacerbations shows promise, but patient severity and co-morbidities impact outcomes. New trials should define patient criteria for accurate assessment of novel antibacterial agents.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Chronic bronchitis is an inflammatory airway disease causing cough and dyspnea, with significant societal costs.
  • Bacterial infections, primarily Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis, trigger exacerbations.
  • Rising antibiotic resistance necessitates new therapeutic strategies for chronic bronchitis exacerbations.

Purpose of the Study:

  • To evaluate the efficacy of antibiotic therapy in acute bacterial exacerbations of chronic bronchitis.
  • To identify factors influencing therapeutic outcomes in chronic bronchitis exacerbations.
  • To guide future clinical trial design for antibacterial agents.

Main Methods:

  • Analysis of a large-scale general practice survey in the UK.

Related Experiment Videos

  • Regression analysis to identify predictors of poor therapeutic outcome.
  • Review of existing literature on antibiotic efficacy and pharmacokinetic properties.

    • Main Results:

    • Patient severity and co-morbid conditions significantly correlate with poor therapeutic outcomes.
    • Antibiotic therapy efficacy is demonstrated in defined exacerbations, though some patients show suboptimal response.
    • Current trials may overestimate antibiotic efficacy due to mild-to-moderate severity patient inclusion.

    Conclusions:

    • Future trials for chronic bronchitis exacerbations must incorporate severity criteria for realistic assessment of antibacterial agents.
    • Improved antibacterial potency and pharmacokinetics are crucial for superior efficacy.
    • Defining patient populations is key to demonstrating real differences between existing and novel compounds.